NCT04840264View on ClinicalTrials.gov

Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction

PHASE2RecruitingINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

January 7, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction AdenocarcinomaPeritoneal Carcinomatosis
Interventions
DRUG

Docetaxel

25 mg/square metre, D1, D8, D15, repeat every 4 weeks.

DRUG

Oxaliplatin

85 mg/msquare metre, D1, D15, repeat every 4 weeks.

DRUG

Fluorouracil

1200 mg/square metre, D1, D8, D15, repeat every 4 weeks.

Trial Locations (1)

510000

RECRUITING

The Sixth Affiliated hosipital, Sun Yat-Sen University, Guangzhou

All Listed Sponsors
lead

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER